T. Rowe Price Mid-Cap Growth Fund, Inc. ALNY Holdings History
T. Rowe Price Mid-Cap Growth Fund, Inc.'s Alnylam Pharmaceuticals Inc Holding Summary
As of 2025-03-31, T. Rowe Price Mid-Cap Growth Fund, Inc. held 1.64 Mil shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $443.70 Mil. This investment constitutes 1.71% of their stock portfolio, and T. Rowe Price Mid-Cap Growth Fund, Inc. now holds 1.26% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.
The initial trade took place in 2019Q3. And since then T. Rowe Price Mid-Cap Growth Fund, Inc. has made 8 purchases of ALNY, at an average price of $118.93, for a total of 2.07 Mil shares. In addition, there have been 9 sales at an average price of $177.53 for 427,900.00 shares. Based on historical transaction data and ALNY's current price of $314.94, T. Rowe Price Mid-Cap Growth Fund, Inc.'s estimated gain on his ALNY holdings is $347.15 Mil, reflecting a 140.93% gain to date.
T. Rowe Price Mid-Cap Growth Fund, Inc. ALNY ($314.94) Holding Chart
T. Rowe Price Mid-Cap Growth Fund, Inc. ALNY ($314.94) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1